These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36812883)
1. Benefits and Harms of Continuous Intravenous Inotropic Support as Palliative Therapy: A Single-Institution, Retrospective Analysis. Rao A; Maini M; Anderson KM; Crowell NA; Gholami SS; Foley Lgsw C; Violanti D; Singh M; Sheikh FH; Najjar SS; Groninger H Am J Hosp Palliat Care; 2024 Jan; 41(1):50-55. PubMed ID: 36812883 [TBL] [Abstract][Full Text] [Related]
2. Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience. Rao A; Anderson KM; Mohammed S; Hofmeyer M; Gholami SS; Sheikh FH; Rodrigo ME; Crowell NA; Javed H; Gupta S; Hajouli S; Stewart DE; Hamad A; Najjar SS; Groninger H J Card Fail; 2021 Sep; 27(9):974-980. PubMed ID: 34153459 [TBL] [Abstract][Full Text] [Related]
3. Disease-State Understanding and Experience of Patients Receiving Continuous Intravenous Inotropic Support as Palliative Therapy: A Multicenter Survey. Maini M; Anderson KM; Seplowe M; Crowell NA; Pitcher C; Scally R; Weintraub WS; Najjar SS; Groninger H; Rao A J Palliat Med; 2024 Apr; ():. PubMed ID: 38564223 [No Abstract] [Full Text] [Related]
4. Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy. Rao A; Singh M; Maini M; Anderson KM; Crowell NA; Henderson PR; Gholami SS; Sheikh FH; Najjar SS; Groninger H Front Cardiovasc Med; 2022; 9():918146. PubMed ID: 36110411 [TBL] [Abstract][Full Text] [Related]
5. Continuous Intravenous Inotropic Support for Advanced Heart Failure: Palliative Considerations. McPherson A; Nguyen C; Groninger H; Anderson KM; Henderson P; Rao A J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):59-67. PubMed ID: 35319327 [TBL] [Abstract][Full Text] [Related]
6. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes. López-Candales AL; Carron C; Schwartz J Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852 [TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure. Martens P; Vercammen J; Ceyssens W; Jacobs L; Luwel E; Van Aerde H; Potargent P; Renaers M; Dupont M; Mullens W ESC Heart Fail; 2018 Aug; 5(4):562-569. PubMed ID: 29341466 [TBL] [Abstract][Full Text] [Related]
8. Ambulatory Inotrope Infusions in Advanced Heart Failure: A Systematic Review and Meta-Analysis. Nizamic T; Murad MH; Allen LA; McIlvennan CK; Wordingham SE; Matlock DD; Dunlay SM JACC Heart Fail; 2018 Sep; 6(9):757-767. PubMed ID: 30007556 [TBL] [Abstract][Full Text] [Related]
9. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. Hershberger RE; Nauman D; Walker TL; Dutton D; Burgess D J Card Fail; 2003 Jun; 9(3):180-7. PubMed ID: 12815567 [TBL] [Abstract][Full Text] [Related]